Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
LC–MS strategies for advanced modalities: ADC, AOC, multidomain and RNA therapeutics 3 days 10 hours 35 mins 31 secs REGISTER NOW

Video: Antibody drug–conjugates characterization (Waters Corporation)

21 May 2015
Chromatography MS (LC–MS/MS, HRMS, IMS)

This video discusses powerful analytical tools which can be used to interrogate and understand ADCs. In particular, it outlines:

  • Characterizing ADCs with hydrophobic interaction chromatography
  • Deriving DAR via native UPLC/MS
  • Resolving positional isomers by 2D UPLC/MS
  • Identifying conjugation by peptide mapping

Top content

  • eBook: Precision bioanalysis for every molecule
  • Global initiative seeks to fast-track personalized therapies for rare diseases
  • Editor’s highlights from NextGen Biomed 2026

Related tags

ADCs LC-MS MS
Previous article Next article

Related articles

21 FEB 2013 GENERAL INTEREST
Study examines accuracy of GC–combustion­–isotope ratio MS doping control analysis
30 JUN 2009 CLINICAL
Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management
8 MAY 2012 DATA PROCESSING AND INTERPRETATION
Development of a method by UPLC–MS/MS for the quantification of tizoxanide in human plasma and its pharmacokinetic application
14 AUG 2019 GENERAL INTEREST
Bioanalytical strategies for PK analysis of antibody–drug conjugate therapeutics using LC–HRMS & LC–MS/MS
13 MAY 2020 BIOMARKERS
Learn with Lin: part I – basic terms in LC–MS
3 SEP 2013 COLLABORATIONS AND MERGERS
Collaboration announced for development of biologics analysis
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone